Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madeleine E Zinser

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 24, 2017
Chronic pancreatitis in patients with liver cirrhosis negatively affects graft survival after liver transplantationMalte H Wehmeyer, Werner Dammermann, Oliver Seiz, et al.
Immunology and Cell Biology|February 10, 2018
Human MAIT cells show metabolic quiescence with rapid glucose-dependent upregulation of granzyme B upon stimulationMadeleine E Zinser, Andrew J Highton, Ayako Kurioka, et al.
The Journal of Infectious Diseases|January 9, 2024
Identification of a Spike-Specific CD8+ T-Cell Epitope Following Vaccination Against the Middle East Respiratory Syndrome Coronavirus in HumansCaroline E Harrer, Leonie Mayer, Anahita Fathi, et al.
Wellcome Open Research|August 27, 2019
Single-cell transcriptome analysis of CD8 <sup>+</sup> T-cell memory inflationAndrew J Highton, Madeleine E Zinser, Lian Ni Lee, et al.
The Journal of Infectious Diseases|November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in HumansJoseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
Ebiomedicine|April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationChristine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trialTill Koch, Christine Dahlke, Anahita Fathi, et al.
The New England Journal of Medicine|April 2, 2015
Phase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeSelidji T Agnandji, Angela Huttner, Madeleine E Zinser, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 24, 2017
Chronic pancreatitis in patients with liver cirrhosis negatively affects graft survival after liver transplantationMalte H Wehmeyer, Werner Dammermann, Oliver Seiz, et al.
Immunology and Cell Biology|February 10, 2018
Human MAIT cells show metabolic quiescence with rapid glucose-dependent upregulation of granzyme B upon stimulationMadeleine E Zinser, Andrew J Highton, Ayako Kurioka, et al.
The Journal of Infectious Diseases|January 9, 2024
Identification of a Spike-Specific CD8+ T-Cell Epitope Following Vaccination Against the Middle East Respiratory Syndrome Coronavirus in HumansCaroline E Harrer, Leonie Mayer, Anahita Fathi, et al.
Wellcome Open Research|August 27, 2019
Single-cell transcriptome analysis of CD8 <sup>+</sup> T-cell memory inflationAndrew J Highton, Madeleine E Zinser, Lian Ni Lee, et al.
The Journal of Infectious Diseases|November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in HumansJoseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
Ebiomedicine|April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationChristine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
The Lancet. Infectious Diseases|April 24, 2020
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trialTill Koch, Christine Dahlke, Anahita Fathi, et al.
The New England Journal of Medicine|April 2, 2015
Phase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeSelidji T Agnandji, Angela Huttner, Madeleine E Zinser, et al.
Pageof 1